Evaluation of Safety and Efficacy of Using Venus Freeze™ (MP)2 V2 System for Wrinkles Rhytides and Cellulite Treatment
NCT ID: NCT01234259
Last Updated: 2020-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2010-12-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Radio-frequency (RF) devices have been used for many years for a variety of surgical applications. The energy delivery systems of these established monopolar devices used a 'conductive coupling' delivery system in which energy is concentrated at the periphery of the electrode.
Venus Concept has developed the Venus Freeze (MP)2 V2 system for wrinkles, rhytides and temporary cellulite and circumference reduction treatments. While treating wrinkles rhytides and cellulite, the treatments creates enough thermal effect to induce collagen remodeling with no ablative thermal damage in the epidermis or dermis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
NCT03776461
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
NCT03831477
Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring
NCT04827680
Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring
NCT03821324
Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles
NCT04057768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Device: Venus Freeze (MP)2 V2 system
Venus Freeze (MP2 V2 System
Facial wrinkles and temporary cellulite and circumference reduction treatments
control group:
Sham comparator
Venus Freeze (MP2 V2 System
Facial wrinkles and temporary cellulite and circumference reduction treatments
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Venus Freeze (MP2 V2 System
Facial wrinkles and temporary cellulite and circumference reduction treatments
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with Fitzpatrick 4 to 9 degrees of elastosis
* Subject able to comprehend and give informed consent for participation in this study
* Subject must commit to all treatments and follow-up visits
* Subject must sign the Informed Consent Form
Exclusion Criteria
* Subjects with any implantable metal device in the treatment area
* Subjects on any medication that would affect the characteristic of the skin (medical or hormonal), such as "Accutane", within the past 6 months or photosensitizing medications
* Subjects that have had any other invasive or non invasive method of skin therapy or hair removal performed in the past 9 months (in the treated area) Subjects who are scheduled or planned for any other invasive or non invasive method of skin therapy or hair removal in the treated area at the period of the study
* Subjects who have any form of malignant skin cancer on the treatment area
* Subjects with history of keloid formations or hypertrophic scarring
* Pregnant or lactating Subjects
* Subjects with Epilepsy or severe migraines
* Subjects with permanent makeup/ tattoo/ body piercing (in the treated area)
* Subjects with any Infection / abscess / dermatitis/ pains in treatment target area.
* Subjects who suffer from autoimmune disorders or diabetes
* Subjects with clotting disorders
* Subjects are suffering from psychiatric disorders and treated with psychiatric medications.
* Subject is suffering extreme general weakness.
* Subject objects to the study protocol
* Concurrent participation in any other clinical study
* Physician objection
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Venus Concept
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eli Sprecher, Prof.
Role: PRINCIPAL_INVESTIGATOR
Tel-Aviv Sourasky medical Centre, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sourasky medical Centre
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VN-WR- 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.